MSc, PhD. After his MSc in medical and pharmaceutical biotechnology at the University of Genoa (IT), Luca Soattin pursued a Marie Skłodowska–Curie PhD programme in cardiac electrophysiology at the University of Copenhagen (DK) and at the University Medical Center Hamburg-Eppendorf (DE). His research mainly focused on in vivo electrophysiology of Adenosine-1 receptors and SK channels in atrial fibrillation, and the implementation of small antisense oligonucleotides for silencing cardiac proteins involved in atrial arrhythmias. Luca Soattin is now Research Associate at the Division of Cardiovascular Sciences (University of Manchester, UK). His main research interests concern the development of atrial fibrillation and sinus node disease models in in vivo large animals with the aim to investigate epicardial-endocardial dissociation mechanisms through multi-electrode array systems for the ablation therapy.